Our breath tells the secrets hidden in our bodies.

Breathe BioMedical is identifying composite biomarkers for routine early disease screening.

Our bodies are one big metabolic reaction producing a plethora of volatile organic compounds (VOCs) which are the basis for our proprietary composite biomarkers. These VOCs are released into the blood and can be detected in our breath. Similar to how dogs and people can smell disease, our technology measures VOCs, the underlying signature of disease.

VOCs in our breath can tell a story about what may be going wrong inside of our bodies. Breathe BioMedical’s technology is being developed to screen for biomarkers of cancer, neurologic and respiratory diseases, often long before symptoms appear.

Our platform combines three advanced technologies to sample, digitize and analyze breath to screen for disease.


Just breathe and we’ll collect a sample ready for the lab.


Our advanced infrared spectrometer translates samples into reliable data sets.


Our machine-learning algorithms unpack the vast and complex data at the molecular level for biomarker identification.